Key terms
About GRTS
Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest GRTS news
Mar 06
7:37am ET
Piper Sandler Sticks to Its Buy Rating for Gritstone Oncology (GRTS)
Mar 06
6:38am ET
Gritstone Oncology’s Strong Financials and Promising Vaccine Trials Fuel Buy Rating
Mar 06
6:20am ET
Analysts Conflicted on These Healthcare Names: ProKidney (PROK), Gritstone Oncology (GRTS) and MicroPort Scientific (OtherMCRPF)
Mar 06
12:30am ET
Analysts Offer Insights on Healthcare Companies: Neuronetics (STIM), Marinus (MRNS) and Gritstone Oncology (GRTS)
Mar 05
4:27pm ET
Gritstone reduced workforce by 40% in February
Mar 05
4:26pm ET
Gritstone reports FY23 EPS ($1.20) vs ($1.32) last year
Mar 01
7:03am ET
Buy Rating Affirmed for Gritstone Oncology Amid Strategic Workforce Reduction and Upcoming Trial Catalysts
Feb 29
4:19pm ET
Gritstone announces 40% reduction in workforce
Feb 28
9:57am ET
Apollo Global upgraded, Dell initiated: Wall Street’s top analyst calls
Feb 28
4:34am ET
Gritstone initiated with an Outperform at JMP Securities
Feb 28
12:40am ET
Analysts Are Bullish on These Healthcare Stocks: Gritstone Oncology (GRTS), Protagonist Therapeutics (PTGX)
Feb 13
7:30am ET
Analysts Offer Insights on Healthcare Companies: Healthcare Services (HCSG), Gritstone Oncology (GRTS) and Silence Therapeutics (SLN)
Feb 13
6:30am ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: CymaBay Therapeutics (CBAY), G1 Therapeutics (GTHX) and Gritstone Oncology (GRTS)
Feb 13
5:13am ET
Buy Rating for Gritstone Oncology: Strategic Progress and Market Potential
Feb 12
8:20am ET
Gritstone Oncology Postpones Phase 2b COVID-19 Vaccine Trial
Feb 12
7:11am ET
Gritstone announces update to comparative Phase 2b COVID-19 trial
Jan 19
6:28am ET
5 Top Penny Stocks to Buy Now, According to Analysts – January 2024
Jan 02
9:20am ET
BTIG Sticks to Its Buy Rating for Gritstone Oncology (GRTS)
Dec 31
5:12am ET
BTIG Sticks to Their Buy Rating for Gritstone Oncology (GRTS)
Dec 22
4:11pm ET
Gritstone files $250M mixed securities shelf
Dec 14
12:21pm ET
Analysts Are Bullish on Top Healthcare Stocks: Gritstone Oncology (GRTS), Vertex Pharmaceuticals (VRTX)
Dec 07
8:21am ET
Gritstone price target lowered to $6 from $8 at B. Riley
Dec 07
2:46am ET
Buy Rating Affirmed for Gritstone Oncology Amid Promising Clinical Trials and Market Potential
No recent news articles are available for GRTS
GRTS Financials
Key terms
Ad Feedback
GRTS Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
GRTS Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range